These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
241 related articles for article (PubMed ID: 30396977)
1. C-Reactive Protein-based Prognostic Measures Are Superior at Predicting Survival Compared with Peripheral Blood Cell Count-based Ones in Patients After Curative Resection for Pancreatic Cancer. Fujiwara Y; Haruki K; Shiba H; Hamura R; Horiuchi T; Shirai Y; Furukawa K; Gocho T; Yanaga K Anticancer Res; 2018 Nov; 38(11):6491-6499. PubMed ID: 30396977 [TBL] [Abstract][Full Text] [Related]
2. The prognostic value of the preoperative c-reactive protein/albumin ratio in ovarian cancer. Liu Y; Chen S; Zheng C; Ding M; Zhang L; Wang L; Xie M; Zhou J BMC Cancer; 2017 Apr; 17(1):285. PubMed ID: 28431566 [TBL] [Abstract][Full Text] [Related]
3. Prognostic Value of the CRP/Alb Ratio, a Novel Inflammation-Based Score in Pancreatic Cancer. Liu Z; Jin K; Guo M; Long J; Liu L; Liu C; Xu J; Ni Q; Luo G; Yu X Ann Surg Oncol; 2017 Feb; 24(2):561-568. PubMed ID: 27650825 [TBL] [Abstract][Full Text] [Related]
4. Clinical Implication of Inflammation-Based Prognostic Score in Pancreatic Cancer: Glasgow Prognostic Score Is the Most Reliable Parameter. Yamada S; Fujii T; Yabusaki N; Murotani K; Iwata N; Kanda M; Tanaka C; Nakayama G; Sugimoto H; Koike M; Fujiwara M; Kodera Y Medicine (Baltimore); 2016 May; 95(18):e3582. PubMed ID: 27149487 [TBL] [Abstract][Full Text] [Related]
5. A Novel Inflammation-Based Stage (I Stage) Predicts Overall Survival of Patients with Nasopharyngeal Carcinoma. Li JP; Chen SL; Liu XM; He X; Xing S; Liu YJ; Lin YH; Liu WL Int J Mol Sci; 2016 Nov; 17(11):. PubMed ID: 27854304 [TBL] [Abstract][Full Text] [Related]
6. The Comparison of Inflammation-Based Prognostic Scores in Patients With Extrahepatic Bile Duct Cancer After Pancreaticoduodenectomy. Fujiwara Y; Haruki K; Shiba H; Hamura R; Shirai Y; Furukawa K; Gocho T; Yanaga K J Surg Res; 2019 Jun; 238():102-112. PubMed ID: 30769246 [TBL] [Abstract][Full Text] [Related]
7. A Novel Inflammation-Based Prognostic Score, the C-Reactive Protein/Albumin Ratio Predicts the Prognosis of Patients with Operable Esophageal Squamous Cell Carcinoma. Xu XL; Yu HQ; Hu W; Song Q; Mao WM PLoS One; 2015; 10(9):e0138657. PubMed ID: 26390126 [TBL] [Abstract][Full Text] [Related]
8. Inflammation scores predict survival for hepatitis B virus-related hepatocellular carcinoma patients after transarterial chemoembolization. Zhou DS; Xu L; Luo YL; He FY; Huang JT; Zhang YJ; Chen MS World J Gastroenterol; 2015 May; 21(18):5582-90. PubMed ID: 25987783 [TBL] [Abstract][Full Text] [Related]
9. A novel inflammation-based prognostic score in esophageal squamous cell carcinoma: the C-reactive protein/albumin ratio. Wei XL; Wang FH; Zhang DS; Qiu MZ; Ren C; Jin Y; Zhou YX; Wang DS; He MM; Bai L; Wang F; Luo HY; Li YH; Xu RH BMC Cancer; 2015 May; 15():350. PubMed ID: 25934640 [TBL] [Abstract][Full Text] [Related]
10. The C-reactive protein/albumin ratio, a novel inflammation-based prognostic score, predicts outcomes in patients with hepatocellular carcinoma. Kinoshita A; Onoda H; Imai N; Iwaku A; Oishi M; Tanaka K; Fushiya N; Koike K; Nishino H; Matsushima M Ann Surg Oncol; 2015 Mar; 22(3):803-10. PubMed ID: 25190127 [TBL] [Abstract][Full Text] [Related]
11. Neutrophil to lymphocyte ratio predicts prognosis in unresectable pancreatic cancer. Iwai N; Okuda T; Sakagami J; Harada T; Ohara T; Taniguchi M; Sakai H; Oka K; Hara T; Tsuji T; Komaki T; Kagawa K; Yasuda H; Naito Y; Itoh Y Sci Rep; 2020 Oct; 10(1):18758. PubMed ID: 33127996 [TBL] [Abstract][Full Text] [Related]
12. Prognostic Significance of the Preoperative Ratio of C-Reactive Protein to Albumin in Patients with Colorectal Cancer. Shibutani M; Maeda K; Nagahara H; Iseki Y; Ikeya T; Hirakawa K Anticancer Res; 2016 Mar; 36(3):995-1001. PubMed ID: 26976989 [TBL] [Abstract][Full Text] [Related]
13. Prognostic impact of the combination of neutrophil-to-lymphocyte ratio and Glasgow prognostic score in colorectal cancer: a retrospective cohort study. Inamoto S; Kawada K; Okamura R; Hida K; Sakai Y Int J Colorectal Dis; 2019 Jul; 34(7):1303-1315. PubMed ID: 31177316 [TBL] [Abstract][Full Text] [Related]
14. Prognostic significance of preoperative C-reactive protein: albumin ratio in patients with clear cell renal cell carcinoma. Chen Z; Shao Y; Fan M; Zhuang Q; Wang K; Cao W; Xu X; He X Int J Clin Exp Pathol; 2015; 8(11):14893-900. PubMed ID: 26823819 [TBL] [Abstract][Full Text] [Related]
15. Comparison of the Glasgow Prognostic Score (GPS) and the modified Glasgow Prognostic Score (mGPS) in evaluating the prognosis of patients with operable and inoperable non-small cell lung cancer. Fan H; Shao ZY; Xiao YY; Xie ZH; Chen W; Xie H; Qin GY; Zhao NQ J Cancer Res Clin Oncol; 2016 Jun; 142(6):1285-97. PubMed ID: 26864695 [TBL] [Abstract][Full Text] [Related]
16. The C-reactive protein/albumin ratio predicts overall survival of patients with advanced pancreatic cancer. Wu M; Guo J; Guo L; Zuo Q Tumour Biol; 2016 Sep; 37(9):12525-12533. PubMed ID: 27344157 [TBL] [Abstract][Full Text] [Related]
17. Preoperative serum C-reactive protein levels and post-operative lymph node ratio are important predictors of survival after pancreaticoduodenectomy for pancreatic ductal adenocarcinoma. Sanjay P; de Figueiredo RS; Leaver H; Ogston S; Kulli C; Polignano FM; Tait IS JOP; 2012 Mar; 13(2):199-204. PubMed ID: 22406601 [TBL] [Abstract][Full Text] [Related]
18. Prognostic value of preoperative NLR, dNLR, PLR and CRP in surgical renal cell carcinoma patients. Hu H; Yao X; Xie X; Wu X; Zheng C; Xia W; Ma S World J Urol; 2017 Feb; 35(2):261-270. PubMed ID: 27255479 [TBL] [Abstract][Full Text] [Related]
19. Preoperative C-reactive protein to albumin ratio is a predictor of survival after pancreatic resection for pancreatic ductal adenocarcinoma. Ikuta S; Aihara T; Yamanaka N Asia Pac J Clin Oncol; 2019 Oct; 15(5):e109-e114. PubMed ID: 30632282 [TBL] [Abstract][Full Text] [Related]
20. Effect of C-reactive protein/albumin ratio on prognosis in advanced non-small-cell lung cancer. Ni XF; Wu J; Ji M; Shao YJ; Xu B; Jiang JT; Wu CP Asia Pac J Clin Oncol; 2018 Dec; 14(6):402-409. PubMed ID: 30178541 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]